search  
 


Home

Who are we?

Why
register?


Signup for
registration


Online registration

Log in to register
your trial


Search a trial

NRT en CCMO

Contact

NEDERLANDS





MetaRegister
van CCT (UK)


ISRCTN-Register
van CCT (UK)


Whole blood thrombin generation test- a clinical validation


- candidate number15673
- NTR NumberNTR4261
- ISRCTNISRCTN wordt niet meer aangevraagd.
- Date ISRCTN created
- date ISRCTN requested
- Date Registered NTR8-nov-2013
- Secondary IDsMETC 12-4-144 
- Public TitleWhole blood thrombin generation test- a clinical validation
- Scientific TitleClinical validation of the whole blood thrombin generation assay
- ACRONYM
- hypothesisWhole blood thrombin generation generates reliable results which are comparable to plasma thrombin generation.
- Healt Condition(s) or Problem(s) studiedBleeding
- Inclusion criteriaPatients undergoing major surgery (major abdominal surgery, aorta aneurysms, major orthopaedic surgery) that have a greater chance to develop a bleeding will be asked to participate to our study. Patient inclusion will only occur when they are suffering from a bleeding during/after major surgery receiving a transfusion of blood products and/or factor concentrates.
- Exclusion criteriaage below 18 years.
Patients with acute life-threatening bleeding.
Patients undergoing cardiothoracic or vascular surgery receiving heparintherapy
- mec approval receivedyes
- multicenter trialno
- randomisedno
- group[default]
- TypeSingle arm
- Studytypeobservational
- planned startdate 11-nov-2013
- planned closingdate11-nov-2014
- Target number of participants60
- InterventionsPatients with controlled bleeding due to non cardiac surgery will receive standard treatment with blood products according to local protocols.
- Primary outcomeWhole blood measeurement before and after treatment compared to standard plasma thrombin generation
- Secondary outcomeparameters of clinical bleeding (transfusion after the second test, fluid substitution)
- TimepointsSamples are taken before and after transfusion.
- Trial web siteN/A
- statusplanned
- CONTACT FOR PUBLIC QUERIESDr. M.D. LancÚ
- CONTACT for SCIENTIFIC QUERIESDr. M.D. LancÚ
- Sponsor/Initiator Maastricht University Medical Center (MUMC+), Synapse b.v. (CARIM)
- Funding
(Source(s) of Monetary or Material Support)
Synapse b.v.
- PublicationsN/A
- Brief summaryRationale: The Calibrated Automated Thrombogram (CAT) assay is nowadays a very helpful tool to measure thrombin generation (TG) in the field of thrombosis and haemostasis research. Unfortunately up to now, it was only possible to perform this assay in platelet rich and poor plasma, but not in whole blood due to technical issues. We were able to overcome these problems and to adapt the CAT assay to make it able of measuring TG in a small volume of whole blood. The advantages are that whole blood is more physiological than plasma and that it can be used directly, reducing not only the time to perform the assay, but also the experimental errors that can occur.
Objective: Our primary objective is to validate our newly developed whole blood TG assay. In order to do this we want to compare and correlate the outcome of the TG assay in whole blood with TG in plasma, and also with the ROTEM, the scanning electron microscopy (SEM) and the routine coagulation tests that are performed in the hospital. Our secondary objective is to compare the results from all tests before and after transfusion of blood products and/or factor concentrates to check whether the improvement in the haemostatic function of the patient can also be detected with our newly developed whole blood TG assay.
Study design: This is a observational, comparative study between the results of the routine coagulation tests that are performed in the hospital, the ROTEM results, the SEM analysis, the results from TG in plasma with our newly developed TG assay in whole blood.
Study population: Patients above the age of 18 that are suffering from a bleeding and are transfused with blood products and/or factor concentrates during/after major surgery.
Main study parameters/endpoints: We are going to compare and correlate all the TG parameters (peak height, endogenous thrombin potential, lagtime, time-to-peak, velocity index) in plasma and whole blood with the SEM pictures (density and thickness of the fibrin network), ROTEM and the routine coagulation tests of the hospital (activated partial thromboplastin time, prothrombin time, INR, fibrinogen concentration, haematocrit, platelet count).
- Main changes (audit trail)
- RECORD8-nov-2013 - 6-dec-2013


  • Indien u gegevens wilt toevoegen of veranderen, kunt u een mail sturen naar nederlands@trialregister.nl